RSC Home > Events > 2011 Risk Science Symposium > Speakers

2011 Risk Science Symposium Speakers

September 20-21 2011
University of Michigan, Ann Arbor, USA

The premier meeting of 2011 addressing the intersection between
technology innovation and human health risk

Dr. Paul Anastas
Assistant Administrator for the Office of Research and Development
Science Advisor to the EPA

Dr. Anastas was unavoidably called away at the last minute and will no longer be speaking at the symposium. We are pleased to announce that he has arranged for Dr. Peter Preuss - Chief Innovation Officer for the U.S. Environmental protection Agency Office of Research and Development (ORD) - to take his place.

James Bagian James P. Bagian
Director of the Center for Healthcare Engineering and Patient Safety
Professor in the Medical School and the College of Engineering
University of Michigan

James P. Bagian, is the Director of the Center for Healthcare Engineering and Patient Safety and is a Professor in the Medical School and the College of Engineering at the University of Michigan. Previously, he served as the first Director of the VA National Center for Patient Safety (NCPS) and the first Chief Patient Safety Officer for the Department of Veterans Affairs from 1999 to 2010 where he developed numerous patient safety related tools and programs that have been adopted nationally and internationally. Dr. Bagian served as a NASA astronaut and is a veteran of two Space Shuttle missions including as the lead mission specialist for the first dedicated Life Sciences Spacelab mission. His primary interest and expertise involves the development and implementation of multidisciplinary programs and projects that involve the integration of engineering, medical/life sciences, and human factor disciplines. Presently, he is applying the majority of his attention to the application of systems engineering approaches to the analysis of medical adverse events and the development and implementation of suitable corrective actions that will enhance patient safety primarily through preventive means. He received his B.S. in mechanical engineering from Drexel University and his M.D. from Jefferson Medical College at Thomas Jefferson University. Dr. Bagian was elected to both the National Academy of Engineering and the Institute of Medicine and has served on or chaired numerous NRC and IOM committees.

Professor James Baker
Ruth Dow Doan Professor of Medicine and Bioengineering
Director of Michigan Nanotechnology Institute for Medicine

Dr. Baker joined the faculty of the University of Michigan in 1989 and is currently Professor of Medicine and Division Chief of Allergy and Clinical Immunology in the Department of Internal Medicine, Professor of Pathology, and Professor of Biomedical Engineering in the School of Engineering at the University of Michigan. In July, 1998 Dr. Baker was appointed Director of the U-M's newly organized Center for Biologic Nanotechnology and in 2001 was inaugurated as the first recipient of the Ruth Dow Doan Endowed Professorship in Biologic Nanotechnology. Following the success of the Center for Biologic Nanotechnology, in April 2005, U-M's Board of Regents formed the Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) and appointed Dr. Baker as its first Director. Under his leadership, MNIMBS merges academic expertise and institutional resources across the university to develop and market applications for nanotechnology in medicine, the biological sciences and the environment.

Dr. Baker's research includes the application of nanomaterials to cellular engineering, drug delivery and gene transfer, and is supported by over $60 million dollars in federal grants and contracts. These studies have produced new vector systems for gene transfer using dendritic polymers with potential to revolutionize pharmaceutical therapy. Dr. Baker’s work with synthetic lipid and polymeric nanostructures has resulted in the development of a new class of antimicrobial agents with activity against bacteria, spores, fungi and viruses. These projects led to two start-up biotechnology companies, NanoBio Corporation and Avidimer Therapeutics, both located in Ann Arbor, Michigan where Dr. Baker serves as the Chief Scientific Officer of both corporations.

Dr. Baker is recognized as both a national and international leader in the fields of Allergy and Clinical Immunology and Biologic Nanotechnology and has attained significant recognition and awards for his work including the 2001 U-M Dean's Innovation Award, given to faculty members whose innovations radically improved or transformed clinic outcomes, educational processes, or research processes. In 2008, he was awarded the Distinguished University Innovator Award, given in recognition of individuals who have made important and lasting contributions to the University of Michigan by their efforts to move new innovations into the private sector for public benefit, and by demonstrating extraordinary entrepreneurial leadership. Dr. Baker serves on the editorial boards of three noteworthy journals and is one of three editors of the National Nanotechnology Initiatives’ Research Directives. Dr. Baker has chaired numerous study sections for NIH and serves on many internal and external advisory boards and committees including the Nanotechnology Technical Advisory Group (N-TAG) of the President's Council of Advisors on Science and Technology (PCAST) for the Executive Office of the President of the United States, the advisory to a sub-committee of the Defense Intelligence Agency and in 2006 began a 5 year appointment as a Director of the American Board of Allergy and Immunology (ABAI).

Professor Mark Banaszak Holl
Associate Vice President-Physical and Natural Sciences, University of Michigan Office of the Vice President for Research, Professor of Chemistry, College of Literature, Science, and the Arts and Professor of Macromolecular Science and Engineering, University of Michigan College of Engineering.

Mark Banaszak Holl is professor of chemistry, biomedical engineering and macromolecular science and engineering, and Associate Vice-President for Research at the University of Michigan. He is a member of the Programs in Applied Physics and Biophysics and the Michigan Nanotechnology Institute for Medicine and Biological Sciences. Prior to coming to Michigan, he held positions at IBM's T. J. Watson Laboratory and Brown University. His research group is active in the areas of targeted drug delivery, the mechanism of gene delivery, the nanoscale structure of bone, and organometallic chemistry. He has received the IBM Research Partnership Award, an Alfred P. Sloan Fellowship, and was elected as a Fellow of the American Association for the Advancement of Science.

Larry Bell
Senior Vice President for Strategic Initiatives at the Museum of Science, Boston
Director of the Nanoscale Informal Science Education Network

Larry Bell is Senior Vice President for Strategic Initiatives at the Museum of Science in Boston and the Director of the Nanoscale Informal Science Education Network, a major NSF initiative to raise public awareness, understanding, and engagement with nanoscale science, engineering, and technology. He has worked in the Education and Exhibit Departments at the Museum of Science in Boston since 1971 where he has served as Education Associate, Director of Exhibit Research and Planning, Head of Exhibits, Vice President for Exhibits, and Sr. Vice President for Research, Development and Production. He led a team of exhibit developers from 1986 to 2008 in implementing a new model for science center exhibits employing contructivist learning experiences to provide visitors with practice in scientific thinking skills. Currently he is also Associate Director of the National Center for Technological Literacy and engaged in developing models for technology and engineering education in informal learning environments, with special attention to forum programs that engage the public in dialogue and deliberation around societal issues associated with new developments in science and technology. He received a B.S. in Physics and an M.S. in Earth and Planetary Science from M.I.T. in 1971.

David Bidwell
Research Fellow, University of Michigan
Serving as program manager for the Great Lakes Integrated Sciences and Assessments Center (GLISA)

David Bidwell is a research fellow at the University of Michigan, serving as the program manager for the Great Lakes Integrated Sciences and Assessments Center (GLISA). GLISA is a NOAA-funded collaboration of U of M and Michigan State University, designed to bridge the gap between research on the impacts of climate change and variability and climate-sensitive decision making. David received his PhD in Sociology from MSU in 2011; his dissertation research focused on public attitudes towards wind farm development. David has also worked on numerous environmental projects as a public participation facilitator and consultant.

Erica Blom
PhD candidate in sociology and public policy

Erica is a PhD candidate in sociology and public policy. She recently completed a project examining contention over seed patenting in Canada and is beginning her dissertation work analyzing stakeholder interaction with environmental impact assessments, assessments which seek to regulate the environmental and socio-economic effects of new technologies such as those in energy development and genetic modification.

Gregory G. Bond, Ph.D., M.P.H., F.A.C.E.
Corporate Director of Product Responsibility
The Dow Chemical Company

Greg Bond is Corporate Director of Product Responsibility for The Dow Chemical Company. He is based in Midland, Michigan. In this position, Greg provides leadership for Dow’s product stewardship programs globally, including experts who ensure Dow’s products are safe for their intended use and comply with all regulatory and Dow requirements He also directs Dow’s Toxicology & Environmental Research and Consulting (TERC) organization which provides testing, research and consultative services for Dow’s businesses.

Greg obtained a Ph.D. in Epidemiology after receiving a Bachelor of Science degree in Microbiology and a Masters degree in Public Health, all from the University of Michigan. He joined Dow as an epidemiologist in 1979. In 1991, he moved to the product stewardship area and was appointed Global Director of Product Stewardship in 1995 and director of TERC in 1998. From March, 2006 until December 1, 2008, Greg held the additional role of Asia Pacific EH&S Director and was based in Shanghai, People’s Republic of China.

Greg has published more than sixty peer-reviewed journal articles on epidemiology research and product stewardship. In 1988, he was elected a Fellow in the American College of Epidemiology. He has served as an advisor to various government agencies, including the U.S. Environmental Protection Agency, the National Institute for Occupational Safety and Health, the National Cancer Institute, the Agency for Toxic Substances and Disease Registries, the Centers for Disease Control, and others. For 3 years, Greg chaired the American Chemistry Council’s Health, Product and Science Policy Team and played a key leadership role in the development of a number of key product stewardship initiatives (e.g., US EPA High Production Chemical Challenge, and the Global Product Strategy). He was also Vice Chairman of the Association of International Chemical Manufacturers, the leading chemical industry association in China.

Greg is currently co-chairing the International Council of Chemical Association’s Chemicals Policy and Health Leadership Group which is working to improve the product safety performance of the global chemical industry, its reputation and strengthen science and risk-based chemicals management legislation and regulation throughout the world. He was the recipient of the 2009 Distinguished Leadership Award from the American Chemistry Council for this work. He is also currently a member of the Dean’s Advisory Board for the School of Public Health at the University of Michigan.

Dr. Diana Bowman
Assistant Professor in the Department of Health Management Policy, School of Public Health
University of Michigan

Dr. Bowman is an Assistant Professor in the Department of Health Management Policy, School of Public Health, at the University of Michigan and a visiting international scholar in the Faculty of Law, KU Leuven (Belgium). In addition to these roles Diana serves as a member on the Australian Government’s National Enabling Technologies Strategy Expert Forum.
Diana’s research has focused primarily on legal, regulatory and public health policy issues relating to new technologies, in particular nanotechnologies. Diana is the co-editor of several books including New Global Frontiers in Regulation: The Age of Nanotechnology (2007, with Hodge and Ludlow) and Nanotechnology Risk Management: Perspectives and Progress (2010, with Hull) and the International Handbook on Regulating Nanotechnologies (2010, with Hodge and Maynard).
Diana has qualifications in science and law (Monash University, 2003), a PhD in Law (2007), and is admitted to practice as an Australian Lawyer.

Larry Busch Dr. Lawrence Busch
University Distinguished Professor of Sociology
Founder and co-director of the Center for the Study of Standards in Society
Michigan State University

Dr. Lawrence Busch is University Distinguished Professor of Sociology and founder and Co-Director of the Center for the Study of Standards in Society at Michigan State University. Until recently he was also Professor of Standards and Society at Lancaster University (UK). He is coauthor or coeditor of a number of books including Plants, Power, and Profit: Social, Economic, and Ethical Consequences of the New Biotechnologies (Blackwell, 1991); From Columbus to Conagra: The Globalization of Agriculture (Kansas, 1994); and Making Nature, Shaping Culture: Plant Biodiversity in Global Context (Nebraska, 1995), The Eclipse of Morality: Science, State, and Market (Aldine deGruyter, 2000), Agricultural Standards (Springer, 2006), Universities in an Age of Corporate Science (Temple, 2007), and most recently, Standards: Recipes for Reality (MIT, 2011), and as well as more than 100 other publications. He is past president of the Rural Sociological Society, past president of the Agriculture, Food, and Human Values Society and a fellow of the American Association for the Advancement of Science. He is a Chevalier de l’Ordre du Mérite Agricole and a member of the Académie d’Agriculture de France. He recently was awarded a Doctor Honoris Causa from the Universidade Técnica de Lisboa. Dr. Busch has worked in France, Norway, Kenya, Brazil, India, and a number of other nations on issues related to food and agriculture. He has been a consultant to the International Service for National Agricultural Research and the Food and Agriculture Organization of the United Nations. He has written and spoken on a variety of social, political, and economic issues associated with food standards, both here and abroad. Dr. Busch’s interests include food and agricultural standards food safety policy, biotechnology policy, agricultural science and technology policy, higher education in agriculture, and public participation in the policy process.

R. Alta Charo
Warren P. Knowles Professor of Law & Bioethics
University of Wisconsin

R. Alta Charo (AB biology, Harvard 1979; JD law, Columbia 1982) is the Warren P. Knowles Professor of Law & Bioethics, University of Wisconsin Law School and School of Medicine & Public Health, where she teaches a variety of courses covering bioethics, public health law, biotechnology policy, and torts. Her government positions have included work as a senior advisor in the Office of the Commissioner at FDA; policy analyst for the US Agency for International Development; and legal analyst for the congressional Office of Technology Assessment. Her service on government advisory bodies includes work as a member of the Obama Administration transition team and the Clinton Administration's National Bioethics Advisory. She is currently a member of the National Academies' Board on Population Health, and was a member of its Board on Life Sciences (2001-2008) and as well as a member of various IOM/NRC committees on bioterrorism, vaccination programs, and drug safety. She was one of the authors of the National Academies' Human Embryonic Stem Cell Research Guidelines and served as a co-chair of its Human Embryonic Research Advisory Committee. She was elected to membership in the Institute of Medicine in 2006.

Julie S. Downs, Ph.D.
Director of the Center for Risk Perception and Communication
Social and Decision Sciences at Carnegie Mellon University

Julie S. Downs, Ph.D., is Director of the Center for Risk Perception and Communication in the department of Social and Decision Sciences at Carnegie Mellon University. Dr. Downs received her Ph.D. in social psychology from Princeton University, and her B.A. in psychology from University of California, Berkeley. She has given invited addresses to a number of distinguished audiences, including the National Academy of Sciences, the Institute of Medicine, the Food and Drug Association, the United States Department of Agriculture, the United Kingdom's Health and Safety Executive, and numerous academic audiences. Her research has been published in psychological, economic, public policy and medical journals.

Britt E. Erickson
Senior editor in the government and policy group
Chemical & Engineering News

Britt E. Erickson is a senior editor in the government and policy group at Chemical & Engineering News, a weekly publication of the American Chemical Society. She regularly writes about environmental health and the risks associated with chemicals, such as nanotechnology, endocrine disrupters, and pesticides. Prior to joining C&EN in 2008, she was the managing editor of the journal Environmental Science & Technology. She has been a reporter at the American Chemical Society since 1997, where she has written numerous news and feature articles for Analytical Chemistry, the Journal of Proteome Research, ES&T, and C&EN. Britt holds a Ph.D. in environmental/analytical chemistry from the University of Maryland, College Park, and a B.S. in chemistry from Radford University in Virginia.

Dr. Adam M. Finkel
Senior Fellow and Executive Director, Penn Program on Regulation and Professor of Environmental and Occupational Health
UMDNJ School of Public Health

Dr. Adam M. Finkel is one of the nation’s leading experts in the evolving field of risk assessment and cost-benefit analysis, with 25 years of experience improving methods of analysis and making risk-based decisions to protect workers and the general public from environmental hazards. He is currently Executive Director of the Penn Program on Regulation at the University of Pennsylvania Law School, where he is also a Senior Fellow, and Professor of Environmental and Occupational Health at the University of Medicine and Dentistry of New Jersey (UMDNJ) School of Public Health. From 2004 to 2007, he was a Visiting Professor of Public and International Affairs at the Woodrow Wilson School at Princeton University. From 2000 to 2003, Dr. Finkel was Regional Administrator for the U.S. Occupational Safety and Health Administration (OSHA) in Denver, Colorado, responsible for regulatory enforcement, compliance assistance, and outreach activities in CO, MT, ND, SD, UT, and WY. From 1995 to 2000, he was Director of Health Standards Programs at OSHA headquarters, and was responsible for promulgating and evaluating regulations to protect the nation’s workers from chemical, radiological, and biological hazards. Dr. Finkel has published more than 40 articles on risk assessment and management in the scientific, legal, and popular literature, and was co-editor of the book Worst Things First? The Debate over Risk-Based National Environmental Priorities (Johns Hopkins Univ. Press, 1994), and of the book Import Safety: Regulatory Governance in the Global Economy (University of Pennsylvania Press, 2009). Previously, he was editor-in-chief of the weekly newsletter “Hazardous Materials Intelligence Report” and an advisor to “Universo Veintiuno,” a research group in Mexico City studying hazardous waste and air pollution problems. From 1991-1994 he was a member of the National Academy of Sciences Committee on Risk Assessment for Hazardous Air Pollutants, and authored a major portion of the committee’s study Science and Judgment in Risk Assessment. From 2006-2008 he was a member of the NAS committee that produced the report Science and Decisions: Advancing Risk Assessment.

Adam has received the David P. Rall Award for Advocacy in Public Health from the American Public Health Association, for “a career in advancing science in the service of public health protection.” He holds an Sc.D. in environmental health sciences from the Harvard School of Public Health, a master’s degree in public policy from Harvard’s John F. Kennedy School of Government, an A.B. in biology from Harvard College, and is a Certified Industrial Hygienist. He lives in Pennington, New Jersey, with his wife Joanne (a clinical psychologist) and 11-year-old daughter Maia; he is also a professional singer and choral conductor.

Bernard Goldstein Bernard D. Goldstein, M.D.
Professor of Environmental and Occupational Health
University of Pittsburgh Graduate School of Public Health

Dr. Goldstein is Professor of Environmental and Occupational Health and the former Dean of the University of Pittsburgh Graduate School of Public Health where he currently heads the Center for Healthy Environments and Communities. He is a physician, board certified in Internal Medicine, Hematology and in Toxicology. Dr Goldstein is author or co-author of over 150 publications in the peer-reviewed literature. He is an elected member of the National Academies of Science Institute of Medicine and of the American Society for Clinical Investigation. His experience includes appointment as Assistant Administrator for Research and Development of the U.S. Environmental Protection Agency, 1983-1985. He has chaired more than a dozen National Research Council (NRC) and IOM committees, most recently the Committee on Sustainability at EPA. He has been president of the Society for Risk Analysis and has served as a member or chairperson of numerous US governmental and WHO committees, including chairperson of the NIH Toxicology Study Section and EPA's Clean Air Scientific Advisory Committee.

David Goldston
Director, Government Affairs
Natural Resources Defense Council

David Goldston became Director of Government Affairs at the Natural Resources Defense Council, a leading environmental group, in July 2009. Prior to that, he had spent more than 20 years on Capitol Hill, working primarily on science policy and environmental policy. He was Chief of Staff of the House Committee on Science from 2001 through 2006. After retiring from government service, Goldston was a visiting lecturer at Princeton University's Woodrow Wilson School of Public and International Affairs in 2007 and at the Harvard University Center for the Environment in 2008 and 2009. From 2007 through November 2009, he wrote a monthly column for Nature on science policy titled "Party of One." Goldston also was the project director for the Bipartisan Policy Center report "Improving the Use of Science in Regulatory Policy," which was released in August 2009. He authored a chapter in The Science of Science Policy: A Handbook (Stanford University Press, 2011). He serves on the National Academy of Sciences' Aeronautics and Space Engineering Board and has served on numerous panels of the Academy and other organizations preparing policy reports. He holds a B.A. (1978) from Cornell University and completed the course work for a Ph.D. in American history at the University of Pennsylvania.

Dan Greenbaum
President and Chief Executive Officer
Health Effects Institute (HEI)

Dan Greenbaum is president and chief executive officer of the Health Effects Institute (HEI), an independent research institute funded jointly by government and industry. He leads HEI's efforts to provide public and private decision makers with high quality, impartial, relevant, and credible science about the health effects of air pollution to inform air quality decisions in the developed and developing world. Mr. Greenbaum focuses HEI on providing timely and critical research and reanalysis on particulate matter, air toxics, diesel exhaust, and alternative technologies and fuels. Prior to joining HEI, he served as Commissioner of the Massachusetts Department of Environmental Protection. He has chaired the U.S. Environmental Protection Agency (EPA) Blue Ribbon Panel on Oxygenates in Gasoline and Clean Diesel Independent Review Panel, and in May 2010, received the Thomas W. Zosel Outstanding Individual Achievement Award from the U.S. EPA for his contributions to advancing clean air. He has also served on several National Research Council Committees, most recently the Committee on the Hidden Costs of Energy. Mr. Greenbaum earned an MS in city planning from Massachusetts Institute of Technology.

Dr. Brian Ivanovic
Senior Vice President
Swiss Re

Brian provides leadership and support to Swiss Re's North American Longevity Research & Development area and to Swiss Re's Global Life Applied Research team. He is a board certified family physician and epidemiologist, with 14 years of reinsurance industry experience. His team conducts insured lives research that assists Swiss Re in the establishment of pricing assumptions and in understanding emerging risk trends affecting health. His research has been published in the Journal of Insurance Medicine and North American Actuarial Journal and a number of Swiss Re’s client publications.

Prior to his insurance industry experiences Brian completed a Fellowship in Academic Medicine at the Medical College of Wisconsin in Milwaukee and spent six years teaching medical students in Des Moines and Milwaukee. He began his medical career as a Flight Surgeon in the US Air Force.

Dr. Ray O Johnson
Senior Vice President and Chief Technology Officer
Lockheed Martin Corporation

Dr. Ray O Johnson, a global executive focused on diversity and innovation, is the Senior Vice President and Chief Technology Officer of the Lockheed Martin Corporation. As an Officer of the Corporation and a member of the executive leadership team, Dr. Johnson guides the Corporation’s technology vision and provides corporate leadership in the strategic areas of technology and engineering, which include more than 70,000 people working on more than 4,000 programs that provide some of the nation’s most vital security systems. He has a proven track record in managing large P&L organizations, strategic planning, program development, program management, and venture capital funding.

Dr. Johnson currently serves as a member of the Sandia Corporation, National Math and Science Initiative, and Hispanic College Fund Boards of Directors. He is a member of the Governing Board of the Indo-US Science and Technology Forum and a sponsor of the DST-Lockheed Martin India Innovation Growth Program. Dr. Johnson is on the US National Institute of Standards and Technology (NIST) Technology Innovation Program (TIP) Advisory Board. He is on the Board of Directors of the Northern Virginia Technology Council and the Virginia Center for Innovative Technology. He is also a member of the Virginia Innovation and Entrepreneurship Investment Authority and the Maryland Federal Facilities Advisory Board. He is a member of the Board of Visitors for the A. James Clark School of Engineering at the University of Maryland, on the Dean’s Advisory Council for the College of Engineering at Carnegie Mellon University, and the chairman of the USA Science and Engineering Festival's Advisory Board.

He is a Full Academician of the International Academy of Astronautics (IAA), a Fellow of the International Society for Optical Engineering (SPIE) and the American Institute of Aeronautics and Astronautics (AIAA), a senior member of the Institute of Electrical and Electronics Engineers (IEEE), and a member of Eta Kappa Nu, Tau Beta Pi, and Phi Kappa Phi. He Chairs the Council on Competitiveness Technology Leadership and Strategy Initiative.

Dr. Johnson holds a B.S., M.S., and Ph.D. degrees in Electrical Engineering.

Mark Jones
Associate Partner and Service Innovation Lead
IDEO Chicago

A thought-leader in the Health Services practice at IDEO Chicago, Mark is committed to designing memorable services that humanize the health-care experience. Recognizing that positive patient outcomes can and should be combined with positive service experiences, Mark has worked closely with such industry giants as the American Red Cross, Blue Cross/Shield, and Geisinger to create innovative offerings that extend the continuity of care and address the unmet needs of everyone from patients and doctors to insurers and pharmaceutical companies. He is especially interested in bridging the physical-digital divide by integrating new ideas and technology — electronic medical records, the Medical Home care model, and convenient self-care services — into current practices.

Before joining our Health Services practice, Mark designed award-winning retail-banking and food-service experiences for Bank of America ("Keep the Change"), PNC ("Virtual Wallet"), and McDonald's, among other major IDEO clients. Trained as a human factors researcher, Mark has 15 years of experience in qualitative and quantitative research methodologies. His career began at Accenture, where he used human-centered design thinking to develop innovative solutions in the areas of smart environments, wireless services, and collaborative tools.

Mark holds a master's degree in design from the Institute of Design at the Illinois Institute of Technology, a bachelor's in fine arts from Amherst College, and an associate's degree in Fashion Design from the Fashion Institute of Technology. When he's not renovating his century-old farmhouse in Michigan, he frequently lectures about service innovation and teaches service design at the Institute of Design at IIT and Northwestern University.

Jörg Lahann
Associate Professor of Chemical Engineering
University of Michigan

Jörg Lahann is an Associate Professor of Chemical Engineering at the University of Michigan and the co-Director of the Institute of Functional Interfaces at the Karlsruhe Institute of Technology (KIT). He received a Ph.D. from the RWTH Aachen, Germany, in Macromolecular Chemistry under the guidance of Prof. H. Höcker. After working as a postdoctoral researcher with Prof. R. Langer at the Massachusetts Institute of Technology, he joined the University of Michigan in 2003. Jörg Lahann is a Recipient of the 2011 DOD Idea award, the 2007 NSEF Award of the AICHE and a NSF-CAREER award. Lahann is a recent fellow of the American Institute of Medical and Biological Engineers and has contributed to more than 100 publications and more than 25 patents or patent applications.

Rodrigo Martinez
Life Sciences Chief Strategist
IDEO

Rodrigo is passionate about the way our understanding of how life works at the genetic, cellular, molecular and systemic levels is transforming products, business, and industries. As member of the Health & Wellness practice, he tackles some of the most interesting design and innovation challenges in health care, life sciences, and the emerging wellness space.

Rodrigo learned to love science-by-doing at the Exploratorium in San Francisco - first as a seven-year-old and later working there as a teenager. Before joining IDEO he was a principal with The Boston Consulting Group in the health care practice. With Juan Enriquez, Rodrigo co-founded Harvard Business School’s Life Sciences Project and coined the term ‘bioeconomy’ in a series of papers and articles starting in 1997. In 2003 he co-published the first global genetic data map selected by Rem Koolhaas to be part of a WIRED’s ‘Ultimate Atlas for the XXI Century.’ HBS Working Papers include “Biotechonomy 1.0: A Rough Map of Biodata Flow,” “SARS, Smallpox, and Business Unusual.”

Rodrigo has worked on projects in 11 countries on topics including innovation and evolution of technology, biopharma R&D, scientific and industrial partnerships, and economic growth and policy. He is a regular guest lecturer at Harvard and MIT on topics including innovation, design and entrepreneurship, health and wellness. Educated at Mexico City’s ITAM and Harvard, Rodrigo mostly learns creativity, innovation, and prototyping from his 4-year-old daughter Sophia.

Andrew Maynard, Ph.D.
Director, University of Michigan Risk Science Center
Professor, Environmental Health Sciences

Prof. Maynard is a leading authority on the responsible development and use of emerging technologies. His research interests span identifying, assessing and managing emergent risks, to exploring innovative solutions to established and emerging human health and environmental risks, to equipping people with the tools they need to make informed decisions in the face of risk and uncertainty. Prof. Maynard is a member of the World Economic Forum Global Agenda Council on the Challenges of Emerging Technologies, serves on numerous review and advisory panels around the world, and has testified on a number of occasions before U.S. Congressional committees. He appears frequently in print and on television and radio, and writes regularly on science and society at http://2020science.org/

David C. Munson, Jr.
Robert J. Vlasic Dean of Engineering and Professor of Electrical Engineering and Computer Science
University of Michigan

David C. Munson, Jr. is the Robert J. Vlasic Dean of Engineering and Professor of Electrical Engineering and Computer Science at the University of Michigan. He received the B.S. degree in electrical engineering from the University of Delaware and the Ph.D. degree in electrical engineering from Princeton University. Professor Munson’s research is focused on signal processing issues in synthetic aperture radar. He is co-founder of InstaRecon, Inc., a start-up to commercialize fast algorithms for image formation in computer tomography. He is co-author of The Infinity Project: Engineering Our Digital Future, a textbook used in about 400 high schools nationwide.

Paula Olsiewski Paula J. Olsiewski
Program Director, Alfred P. Sloan Foundation

A chemist by training, Dr. Paula J. Olsiewski is a program director at the Alfred P. Sloan Foundation, where she develops strategies and guides Foundation grant-making in support of basic scientific research. She directs the Foundation’s Synthetic Biology program, which focuses on ethical, social and public policy issues. Sloan’s Synthetic Biology portfolio includes projects at the Woodrow Wilson International Center for Scholars to examine risk and at the Hastings Center to examine ethical issues. From 2000 to 2011, Dr. Olsiewski directed the Foundation’s Biosecurity program, which focused on citizen and business preparedness as well as on issues of potentially dangerous research in the life sciences.

Gilbert Omenn
Professor of Internal Medicine, Human Genetics, and Public Health and Director of the Center for Computational Medicine & Bioinformatics and the Proteomics Alliance for Cancer Research
University of Michigan

Gilbert Omenn is Professor of Internal Medicine, Human Genetics, and Public Health and Director of the Center for Computational Medicine & Bioinformatics and the Proteomics Alliance for Cancer Research at the University of Michigan. He served as Executive Vice President for Medical Affairs and as Chief Executive Officer of the University of Michigan Health System from 1997 to 2002. He was Dean of the School of Public Health, and Professor of Medicine and Environmental Health, University of Washington, Seattle, 1982-1997. His research interests include cancer proteomics, chemoprevention of cancers, public health genetics, computational biology, science-based risk analysis, and health policy. He was principal investigator of the beta-Carotene and Retinol Efficacy Trial (CARET) of preventive agents against lung cancer and heart disease; director of the Center for Health Promotion in Older Adults; and creator of a university-wide initiative on Public Health Genetics in Ethical, Legal, and Policy Context while at the University of Washington and Fred Hutchinson Cancer Research Center. He served as Associate Director, Office of Science and Technology Policy, and Associate Director, Office of Management and Budget, in the Executive Office of the President in the Carter Administration.

He was in the intramural program of NIH in the Anfinsen Lab in 1967-69 as a LCDR in the USPHS. He has had NIH grants over four decades. He served on the National Cancer Advisory Board, the NHLBI Advisory Council, the Society of Fellows for the National Center for Minority Health and Health Disparities, and the Director’s Advisory Committee of the CDC. He is a director of Amgen Inc. and Armune Biosciences Inc. He leads the Plasma Proteome Project for the international Human Proteome Organization. He was president of the American Association for the Advancement of Science (AAAS) in 2006. He was elected an Ambassador of the Research!America Paul G. Rogers Society for Global Health, serves on the advisory board for the Shanghai Jiao Tong University Medical School, and is active in numerous international health and science policy initiatives.

Omenn is the author of 487 research papers and scientific reviews and author/editor of 18 books. He is a member of the Institute of Medicine of the National Academy of Sciences, the American Academy of Arts and Sciences, the Association of American Physicians, and the American College of Physicians. He chaired the presidential/congressional Commission on Risk Assessment and Risk Management (“Omenn Commission”), served on the National Commission on the Environment, and chaired the NAS/NAE/IOM Committee on Science, Engineering and Public Policy. He received the John W. Gardner Legacy of Leadership Award from the White House Fellows Association in 2004 and the Walsh McDermott Medal from the Institute of Medicine in 2008 for long-term contributions to the IOM and the National Academy of Sciences.

He is active in cultural and educational organizations, a musician and tennis player. Omenn received his B.A. summa cum laude from Princeton, M.D. magna cum laude from Harvard Medical School, and Ph.D. in genetics from the University of Washington.
Website: www.med.umich.edu/omenn.

Rae Ostman
Director of National Collaborations at the Sciencenter, Ithaca, NY

Rae Ostman is Director of National Collaborations at the Sciencenter in Ithaca, NY, where she leads exhibit, program, and media development projects with a nationwide scope. Current projects include the Nanoscale Informal Science Education Network (NISE Net). Previous appointments include: Director of Education at the Sciencenter; Manager of Exhibits at the Exploratorium in San Francisco; Project Manager at the Exploratorium; Project Director at Acoustiguide in New York; and Educator at the Museum of the Moving Image in New York. Ostman received a BA from Cornell University in 1994 in Cultural Analysis of Arts, an MA in Anthropology from New York University in 1997, and a PhD in Anthropology from New York University in 2002.

Shobita Parthasarathy
Associate Professor and Co-Director of the Science, Technology, and Public Policy Program at the Ford School of Public Policy, University of Michigan

Shobita Parthasarathy is Associate Professor and Co-Director of the Science, Technology, and Public Policy Program at the Ford School of Public Policy, University of Michigan. She holds a BA (Biology) from the University of Chicago, and Masters and PhD degrees (Science and Technology Studies) from Cornell University. Her research focuses on the governance of emerging science and technology, with a focus on areas that have uncertain ethical, social, environmental, health, legal, and political implications. She is the author of numerous articles and a book entitled, Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care (Cambridge, MA: MIT Press, 2007). She is working on her second book, which compares the politics of patents on life forms and traditional knowledge in the United States and Europe.

Carlos Peña, Ph.D., M.S.
Director of Emerging Technology Programs in the Office of the Chief Scientist, Office of the Commissioner, at the U.S. Food and Drug Administration (FDA).

Dr. Carlos Peña is Director of Emerging Technology Programs in the Office of the Chief Scientist, Office of the Commissioner, at the U.S. Food and Drug Administration (FDA). He currently serves a lead role in the development of the agency's position and current thinking on emerging technology areas, with an emphasis on nanotechnology. His position includes service on the FDA Nanotechnology Task Force composed of key officials across the agency and establishing and enhancing partnerships with national and international regulatory agencies as well as other stakeholders focused on nanotechnology. He also serves as Chair of the FDA Standards Committee, a committee dedicated to ensuring effective participation by FDA in the development of both domestic and international standards relevant to emerging technologies and other product areas.

Before joining FDA, Dr. Peña served at the National Institute of Neurological Disorders and Stroke, National Institutes of Health. He completed his neurosciences doctoral training at Case Western Reserve University in Cleveland, Ohio. Prior to graduate school, he attended the University of Connecticut for the Masters in Comparative Physiology, and the City College of New York, City University of New York, where he received a Bachelors specializing in Developmental Biology.

Martin Philbert
Dean, University of Michigan School of Public Health

Dr. Philbert is a Professor of Toxicology and Dean of the University of Michigan School of Public Health. His research focuses on the development of flexible polymer nanoplatforms for optical sensing of ions and small molecules and the early detection and treatment of brain tumors. Other research interests include the mitochondrial mechanisms of chemically-induced neuropathic states. Dr. Philbert served as the Vice-Chair of the National Academies National Research Council (NCR) Committee for the Review of the Federal Strategy to Address Environmental, Health, and Safety Research Needs for Engineered Nanoscale Materials, and Chaired of the FDA Science Board Committee on Bisphenol A. Dr. Philbert served on the National Advisory Environmental Health Council of the National Institute of Environmental Health Sciences and provides consultation to Federal agencies on a variety of issues surrounding emerging nanotechnologies. He is a standing member of the USFDA Science Advisory Board and the USEPA Board of Scientific Counselors.

Dr. Peter Preuss
Chief Innovation Officer
Office of Research and Development (ORD), U.S. Environmental Protection Agency

Dr. Peter Preuss is the Chief Innovation Officer in the Office of Research and Development (ORD), U.S. Environmental Protection Agency. He leads an interdisciplinary team charged with building an innovation infrastructure for science that will move EPA forward on the path to sustainability. In their first year, Dr. Preuss and his team have already introduced several innovative ideas and approaches to ORD, including the use of collaborative platforms for research planning and competitive internal awards to promote high-risk, high-reward research. The team has established a cross agency innovation workgroup to help EPA make effective use of open innovation challenges, prizes and awards delegated under the America Competes Act. Additionally, the team has launched an environmental pavilion on InnoCentive.com; a company that specializes in open source innovation for scientific and technical challenges. Currently Dr. Preuss and team are working closely with ORD’s National Program Directors on high profile signature projects oriented around topics such as sustainabile alternatives to toxic chemicals and net zero structures and communities. As his team endeavors to promote new air monitoring sensors and applications to enhance citizen science and citizen empowerment, Dr. Preuss continues to work to bring innovative science and technology research to the forefront of ORD’s activities.

Peter has kindly agree to stand in for Paul Anastas, who was unavoidably called away at the last minute.

Ahleah Rohr Daniel, Ph.D.
Masters of Public Health Student, University of Michigan

Ahleah Rohr Daniel received her Bachelor’s Degree in Science with a concentration in Chemistry from the University of Cincinnati. While there, she conducted research in the laboratory of Dr. Anna D. Gudmundsdottir. Ms. Rohr Daniel completed her Ph.D. in Organic Chemistry at the University of Michigan under the guidance of Professors John P. Wolfe and Mark M. Banaszak Holl. Her thesis research focused on the use of benign organometallic complexes in chemical synthesis and the effective implementation of safety and chemical hygiene protocols in the undergraduate curriculum. She is currently pursuing a Master’s Degree in Industrial Hygiene with a concentration in Hazardous Substances at the University of Michigan School of Public Health.

Dr. Larisa Rudenko
Food and Drug Administration Director of Animal Biotechnology
Center for Veterinary Medicine

Dr. Rudenko serves the Food and Drug Administration Director of Animal Biotechnology at the Center for Veterinary Medicine. In that capacity, she has worked within the agency, at the USG coordinating level, and with public and private sector stakeholders to develop a coherent, science-based policy for the regulation of animal biotechnology. She been responsible for the successful development and implementation of new paradigms for the risk assessment of animal clones and genetically engineered animals by working with diverse groups of subject area experts. Dr. Rudenko is recognized internationally as an expert in animal biotechnology, having served on a European Food Safety Authority working group on animal cloning, FAO-WHO Codex Alimentarius Task Forces and Expert Consultations, OECD Working Groups, international and US federal grant study sections, program review committees, and scientific advisory panels to the US government and industry sectors. Dr. Rudenko received her AB degree from Bowdoin College (Biology, Music) and her PhD in Cellular and Molecular Pharmacology from the State University of New York at Stony Brook (Brookhaven National Laboratory), and is a Diplomate of the American Board of Toxicology.

Ann Marie Sastry, Ph.D.
CEO and Co‐Founder, Sakti3
Arthur F. Thurnau Professor of Mechanical, Biomedical and Materials Science and Engineering
University of Michigan

Sastry is an entrepreneur, researcher and educator in energy science and technology. She and her teams have worked in battery technologies, and also on fundamental problems in mathematics, mechanics, biology and electrochemistry. Her longstanding research and partnerships in battery technologies led her and her co‐founders to form Sakti3, a high‐tech, advanced battery manufacturing company in 2008. Dr. Sastry is on leave as the Arthur F. Thurnau Professor of Engineering at the University of Michigan. She holds Ph.D. and M.S. degrees from Cornell University, and a B.S. from the University of Delaware in Mechanical Engineering.

Don Scavia
Director, University of Michigan Graham Environmental Sustainability Institute

Dr. Scavia is Graham Family Professor of Sustainability, Professor of Natural Resources & Environment and Civil & Environmental Engineering, and Special Counsel to the U-M President for Sustainability. He combines numerical models and integrated assessments to understand the impacts of land use on coastal and freshwater ecosystems, is on the Board of Directors of the Great Lakes Observing System, advisory boards for the Environmental Law and Policy Center and the Healing our Waters Great Lakes Coalition, and on the NWF Great Lakes Leaders Council. He was SNRE Research Dean, Michigan Sea Grant Director, NOAA Cooperative Institute Director, and Editor for Estuaries and Coasts and Frontiers in Ecology and Environment. He holds BS, MS, and PhD degrees in Environmental Engineering from Rensselaer Polytechnic Institute and the University of Michigan, has published over 70 articles in the primary literature, and led development of dozens of interagency scientific assessments and program development plans.

Jo Anne Shatkin, Ph.D.
Chief Executive Officer, CLF Ventures

Jo Anne Shatkin, Ph.D. leads CLF Ventures, a non-profit affiliate of the Conservation Law Foundation, and is a recognized expert on risk assessment of nanotechnologies and nanomaterials Her research focuses on using streamlined life cycle risk analysis to guide sound nano-enabled product development. She advises and assists public and private organizations on technical, strategic and regulatory aspects of nanotechnology risks, and organizes and presents courses and workshops on nanotechnology and risk.

She received her Ph.D. in Environmental Health Science and Policy in 1994 and her MA in Risk Management and Technology Assessment, both from Clark University, Worcester, Massachusetts and possesses a Bachelor of Science degree from Worcester Polytechnic University in Molecular Biology and Biotechnology. She is a research fellow of the George Perkins Marsh Institute at Clark University.

Dr. Michael Siegrist
Professor for Consumer Behavior
Institute for Environmental Decisions (IED), ETH Zurich, Switzerland

Prof. Siegrist studied psychology, economics and mass communication at the University of Zurich. During 1998-2000 he was a visiting researcher at Western Washington University, WA, USA. In 2001 he completed his ‘Habilitation’ at the Faculty of Arts at the University of Zurich. Since 2007 he is a Professor at ETH Zurich. Professor Siegrist has published numerous articles about risk perception, trust, risk communication and risk management. His research focuses, at the moment, on gene technology, nuclear power, climate change issues, food hazards and risk communication in the medical field. He is an Area Editor of the Journal Risk Analysis.

Spink John W. Spink, Ph.D.
Assistant Professor and Associate Director for the Anti-Counterfeit and Product Protection Program, Michigan State University

John Spink, Ph.D., is an Assistant Professor and Associate Director for the Anti-Counterfeit and Product Protection Program (A-CAPPP) at Michigan State University. Before helping merge a number of research and outreach activities into the A-CAPPP concept with the School of Criminal Justice, in 2005 he created the Packaging for Food and Product Protection Initiative (P-FAPP). The key node in the evolution of P-FAPP to A-CAPPP was the May 2007 Executive Forum where eighteen members of industry, agencies, associations and academics emphasized the need for curriculum (defining the entire discipline) before initiating research. This 2007 Forum helped shift the focus from tactical solutions to the overall strategic perspective. The concept took another key step forward when he was invited to present Defining Food Fraud & The Chemistry of the Crime at the FDA Open Meeting on Economically Motivated Adulteration. Spink was an Instructor in the MSU Online Master of Science in Food Safety program and developed and teaches on-line graduate classes including "Anti-Counterfeit and Product Protection" (2008), the packaging module of "Food Protection and Defense" (2006) and "Packaging for Food Safety" (2005). He serves on the State of Michigan's Agriculture and Food Protection Strategy Team, as the Chair of the US Technical Advisory Group (US TAG) for the International Standards Organization's Technical Committee, 247 Fraud Control and Countermeasures (ISO/TC 247 - which includes anti-counterfeiting and product fraud), as a Committee Member on US Pharmacopeia's (USP) Food Ingredient Intentional Adulteration Expert Panel, and as the Chair of the International Association of Packaging Research Institutes (IAPRI) Anti-Counterfeiting and Product Security Working group Spink has 15 years experience in industry - 12 of which were with Chevron Corporation. Spink directs Executive Education and research programs within A-CAPPP. He is a fourth generation MSU Alumni and a third generation Big Ten faculty member.

John Stone, Ph.D.
Co-Director, Center for the Study of Standards in Society, Michigan State University

John V. Stone is Co-Director and Senior Research Scientist at the Center for the Study of Standards in Society (CS3) at Michigan State University. He holds a Ph.D. in Applied Anthropology from the University of South Florida, with an emphasis on Social Impact Assessment (SIA). Dr. Stone has 25+ years experience in applied social research, authored more than 30 scientific publications and technical reports, and delivered more than 85 presentations to professional and scientific societies and government agencies. His current work addresses ethnographic approaches to risk perception mapping, public engagement and standards in the SIA of emerging technologies. Within this context he seeks to promote ‘participatory equity’ among potentially affected populations and increase their social access to policy-making processes. Dr. Stone has held notable positions with the International Association for Great Lakes Research, the National Oceanographic and Atmospheric Administration's Great Lakes Environmental Research Laboratory, and the Great Lakes Commission. He interned at the Oak Ridge National Laboratory and later helped develop the Risk Perception Mapping (RPM) methodology at the University of Michigan's Institute for Social Research. Dr. Stone holds a seat on the Nanotechnology Standards Panel of the American National Standards Institute, co-founded the Risk Assessment and Policy Association, is a Fellow of the Society for Applied Anthropology, a founding member of the Society for Nano and Emerging Technologies, and he holds occasional membership in the International Association for Public Participation and the International Association for Impact Assessment. He was awarded the Environmental Protection Agency's Environmental Anthropology Fellowship in 1999, served as the Inaugural Fellow to the Great Lakes Commission Fellowship Program, and as an invited participant to the Environmental Protection Agency's National Dialogue on Public Involvement in EPA Decisions.

Hilary Sutcliffe
Director of MATTER

Hilary is the Director of MATTER and was previously the Director of the Responsible Nano Forum which she founded in 2008.
Prior to that she ran the secretariat of the Responsible Nano Code - a multi-stakeholder initiative to develop a principles-based code of conduct for companies involved in the development of nanotechnologies.
Following a career in communications in London and New York she founded Shared View an organisation focusing on multi-stakeholder engagement, corporate responsibility and improving understanding of social and ethical issues among all stakeholders. Her expertise includes multi-stakeholder project development, public involvement, corporate responsibility, communications and media relations.

MATTER is a new 'action tank' dedicated to having new technologies work for us all.
It acts as a catalyst to encourage everyone play their part, including governments, business, ngos and the public - and to draw attention to three key areas:

1 The creation of governance frameworks which are a not a barrier but a catalyst for the development and use of new technologies to benefit mankind and the environment.

2 The need to consider and respond to social, ethical and environmental issues alongside the economic and the technical.

3 The importance of involving the public and all stakeholders in the development and use of new and emerging technologies.

The MATTER approach focuses on multi-stakeholder engagement and facilitation, action research, communication and the initiatives we create ourselves to fulfil our aims.

John Viera
Director of Sustainability & Vehicle Environmental Matters
Ford Motor Company

As Director of Sustainability & Vehicle Environmental Matters, Viera is responsible for developing global sustainable business plans and policies, interfacing with global regulatory bodies, reporting externally on the company's environmental and social performance, and leading the company's engagement and partnerships with non-government organizations (NGOs) and other external stakeholders. Prior to his appointment as Director, Viera held several planning, engineering, and manufacturing positions during his 27 year tenure. Highlights include leading the company efforts in the development of its first natural gas pickup truck, serving as Chief Engineer for both the company's Compact Pickups and its Full Size SUVs. Viera led the company's mid term cost reduction efforts, building a team that delivered $1.2 billion of savings in eighteen months. Viera currently serves on the advisory board at Georgia Institute of Technology in Atlanta. Viera holds a B.S. in Mechanical Engineering and an MBA from the University of Michigan.

Jameson Wetmore
Assistant Professor
Arizona State University

Jameson Wetmore is an assistant professor at Arizona State University where he works with the Center for Nanotechnology in Society; the Consortium for Science, Policy & Outcomes; and the School of Human Evolution & Social Change. His work combines the fields of science and technology studies, ethics and public policy in order to better understand both the interconnected relationships between technology and society and the forces that change those relationships over time. He has studied the history of automobile safety, the Amish use of technology, and the methods by which to help scientists and engineers better understand the social impacts of their research.

Kyle Powys Whyte
Assistant Professor of Philosophy and affiliated faculty at the Center for the Study of Standards in Society, the Peace and Justice Studies Specialization, and the American Indian Studies Program.

Kyle Powys Whyte is an Assistant Professor of Philosophy and affiliated faculty at the Center for the Study of Standards in Society (CS3), the Peace and Justice Studies Specialization, and the American Indian Studies Program. He is an enrolled member of the Citizen Potawatomi Nation in Shawnee, Oklahoma. Dr. Whyte writes on issues in environmental justice, the philosophies of science and technology, and American Indian philosophy. His articles are published in journals such as Synthese, Agricultural & Environmental Ethics, Knowledge, Technology & Policy, Ethics, Place & Environment, Continental Philosophy Review, Environmental Philosophy, Philosophy & Technology, Public Integrity, and Rural Social Sciences, and his research has been funded by the National Science Foundation, Spencer Foundation, and National Endowment for the Humanities. He is a member of the American Philosophical Association Committee on Public Philosophy, Michigan Environmental and Natural Resources Governance Program, and Michigan Environmental Justice Working Group, and is a 2009 recipient of the K. Patricia Cross Future Leaders Award from the Association of American Colleges & Universities.

Dr. James Wilsdon
Director, Science Policy Centre at the Royal Society, the UK's national academy of science

Dr James Wilsdon is Director of the Science Policy Centre at the Royal Society, the UK's national academy of science. The Centre's work is organised under four themes - sustainability, diplomacy, innovation and governance – and its recent reports include ‘Geoengineering the Climate: science, governance and uncertainty’ (Sept 2009), ‘Reaping the Benefits: science and the sustainable intensification of global agriculture’ (Nov 2009), ‘New frontiers in science diplomacy’ (Jan 2010), 'The Scientific Century' (March 2010) and 'Knowledge, Networks and Nations' (March 2011). Prior to joining the Royal Society in 2008, James spent seven years as Head of Science and Innovation at the London-based think tank Demos, where his publications included ‘The Atlas of Ideas' (2007), 'China: the next science superpower?' (2007), 'The Public Value of Science' (2005) and 'See-through Science' (2004).

David Zaruk
Assistant Professor Adjunct in Communications
Vesalius College

David is presently an Assistant Professor Adjunct in Communications at Vesalius College, VUB, and Facultés universitaires St-Louis in Brussels, a Senior Associate Research Fellow at the Institute for European Studies, VUB, specialised in EU Environmental Health Policy, and a Risk Governance Analyst at Risk Perception Management, a Brussels-based consultancy. He sits on the European Commission DG Research Ethics Panel, and frequently serves as an expert, rapporteur or evaluator for various DG Research projects. David worked twelve years in chemicals issue management for Solvay, Cefic and Burson-Marsteller. In 2001, he was one of the founders of GreenFacts, a science-based environmental-health risk communications tool for non-specialists.

Dr Brian Zikmund-Fisher
Assistant Professor, Health Behavior and Health Education
Research Assistant Professor, Internal Medicine
University of Michigan

Prof. Zikmund-Fisher has an interdisciplinary background in decision psychology, behavioral economics, and health communication, which he uses to explore the factors that affect decision making about health, medical and environmental risks. Current research projects examine the use of graphical representations to improve understandings of risk, the effects of poor numeracy (people's ability to interpret quantitative information) on decision making about risk, community perceptions of the uncertain risks of environmental exposure, and novel techniques for communicating both genetic and medical treatment-induced risks.

Thomas H. Zurbuchen
Associate Dean for Entrepreneurial Programs, Professor for Space Science and Aerospace Engineering,
College of Engineering, University of Michigan

Prof. Thomas Zurbuchen is the Associate Dean of Entrepreneurial Programs in the College of Engineering. In this function, he oversees entrepreneurship-focused classes and academic programs; grants focused on translating research to commercialization, and also programs supporting ventures by faculty and students. Zurbuchen is a professor in the Department of Atmospheric, Oceanic and Space Science where he does research on the robotic exploration of space. He holds a PhD in Astrophysics from the University of Bern, Switzerland. He has received numerous awards, including the prestigious U.S. Presidential Early Career Award. Zurbuchen has served as part of National Research Council activities and on numerous advisory panels to NASA, NSF and the Department of Labor.